Investigational New Drug Applications: A 1-Year Pilot Study on Rates and Reasons for Clinical Hold

Abstract

The vast majority of initial INDs moved forward within 30 days after submission, and for those applications placed on hold, most became active within 1 year. The findings also suggest that many holds for new drug product programs can be avoided by following the available guidelines for investigational product development.